Lucian Iancovici, MD
Dr. Iancovici serves as a member of the Board of Directors for Sling Therapeutics, Inc.
Dr. Iancovici is currently a Managing Director at TPG Life Sciences Innovation, where he has been since 2018. He currently serves as a Board member at ViaCyte, Sionna, RallyBio, Anovo and Ceribell. Dr. Iancovici previously worked at dRx Capital AG, Qualcomm Ventures and McKinsey & Company.
Dr. Iancovici holds a bachelor’s degree in Economics and a medical degree from Tufts University. He completed his residency in internal medicine at Columbia Presbyterian.